Effects of 1,25 (OH)2 D3 Treatment on Lipid Levels in Uremic Hemodialysis Patients

No abstract is available for this paper.

• Publication year

  1992

• Venue

  International Journal of Artificial Organs

• Publication date

  1992-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/039139889201501204PMID 1493945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.

  2009cited by this paper
• Serum lipid and lipoprotein concentrations in chronic uremia.

  2009cited by this paper
• Insulin release from pancreatic islets: effects of CRF and excess PTH.

  1988cited by this paper
• Partial correction of lipid disturbances by insulin in experimental renal failure.

  1986cited by this paper
• Serum lipoprotein disturbances in primary and secondary hyperparathyroidism and effects of parathyroidectomy.

  1986cited by this paper
• Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

  1985cited by this paper
• Lipid fractions in primary hyperparathyroidism before and after surgical cure.

  1983cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Parathyroid function and lipid metabolism in the rat.

  1982cited by this paper
• Lipid abnormalities in uremia, dialysis, and transplantation.

  1981cited by this paper
• Tissue lipoprotein lipase activity and its action in lipoprotein metabolism.

  1981cited by this paper
• Phosphate, calcium and lipid metabolism.

  1980cited by this paper
• Glucose and lipoprotein metabolism in primary hyperparathyroidism. Effects of parathyroidectomy.

  1978cited by this paper
• Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat.

  1978cited by this paper
• Parathyroid Hormone and Triglyceride Transport: Effects on Triglyceride Secretion Rates and Adipose Tissue Lipoprotein Lipase in the Rat

  1978cited by this paper
• THE ASSAY OF 1α, 25‐DIHYDROXYVITAMIN D3: PHYSIOLOGIC AND PATHOLOGIC MODULATION OF CIRCULATING HORMONE LEVELS

  1976cited by this paper
• Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.

  1976cited by this paper
• CARBOHYDRATE METABOLISM IN UREMIA: A REVIEW

  1973cited by this paper
• TURNOVER OF ENDOGENOUS PARATHYROID HORMONE IN UREMIC PATIENTS AND THOSE UNDERGOING HEMODIALYSIS

  1972cited by this paper
• Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.

  1969cited by this paper
• SECONDARY HYPERPARATHYROIDISM AND RENAL OSTEO‐DYSTROPHY IN CHRONIC RENAL FAILURE: ANALYSIS OF 195 PATIENTS, WITH OBSERVATIONS ON THE EFFECTS OF CHRONIC DIALYSIS, KIDNEY TRANSPLANTATION AND SUBTOTAL PARATHYROIDECTOMY

  1969cited by this paper
• Hypertriglyceridemia. A metabolic consequence of chronic renal failure.

  1968cited by this paper
• Kidney, parathyroid, and lipemia.

  1965cited by this paper

• Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease

  2022cites this paper
• Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways

  2022cites this paper
• Association of Vitamin D Status With Liver and Kidney Disease: A Systematic Review of Clinical Trials, and Cross-Sectional and Cohort Studies.

  2019cites this paper
• Relationship of Vitamin D, HIV, HIV Treatment, and Lipid Levels in the Women’s Interagency HIV Study of HIV-Infected and Uninfected Women in the United States

  2014cites this paper
• Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials

  2012cites this paper
• The role of vitamin D in dyslipidemia and cardiovascular disease.

  2011cites this paper
• Vitamin D and metabolic syndrome: is there a link?

  2010cites this paper
• Osteoporosis and atherosclerosis in chronic renal failure

  2010cites this paper
• Is calcitriol life-protective for patients with chronic kidney disease?

  2009cites this paper
• EFFECTS OF CALCITRIOL (1,25(OH)2D3 TREATMENT ON CONTROL OF GLUCOSE INTOLERANCE IN HEMODIALYSIS PATIENTS

  2008cites this paper
• Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.

  2003cites this paper
• Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene.

  2002cites this paper
• Effect of Vitamins on the Lipid Profile of Patients on Regular Hemodialysis

  2000influential citation
• Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes.

  1999cites this paper
• Effect of metabolic acidosis on hyperlipidemia in uremia

  1999cites this paper
• Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

  1998cites this paper
• Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.

  1997cites this paper
• Correlation of Serum Magnesium and Serum Lipid Levels in Hemodialysis Patients

  1997cites this paper
• Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure. Both are essential to prevent of suppress toxic hyperparathyroidism.

  1996cites this paper
• Intravenous calcitriol normalizes insulin sensitivity in uremic patients.

  1995cites this paper